{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:13:52Z","timestamp":1790957632996,"version":"4.1.0"},"reference-count":80,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Metabolism &amp; Toxicology"],"published-print":{"date-parts":[[2021,6,3]]},"DOI":"10.1080\/17425255.2021.1921735","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T08:51:08Z","timestamp":1619167868000},"page":"697-705","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":18,"title":["Potential drug-drug interaction between sodium-glucose co-transporter 2 inhibitors and statins: pharmacological and clinical evidence"],"prefix":"10.1080","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8245-1758","authenticated-orcid":false,"given":"Panagiotis-Nikolaos","family":"Lalagkas","sequence":"first","affiliation":[{"name":"Laboratory of Hygiene and Environmental Protection, Department of Medicine, Democritus University of Thrace, Alexandroupolis, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5909-3526","authenticated-orcid":false,"given":"Georgios","family":"Poulentzas","sequence":"additional","affiliation":[{"name":"Laboratory of Hygiene and Environmental Protection, Department of Medicine, Democritus University of Thrace, Alexandroupolis, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7835-8246","authenticated-orcid":false,"given":"Christos","family":"Kontogiorgis","sequence":"additional","affiliation":[{"name":"Laboratory of Hygiene and Environmental Protection, Department of Medicine, Democritus University of Thrace, Alexandroupolis, Greece"},{"name":"Institute of Agri-Food and Life Sciences, Hellenic Mediterranean University Research Centre, Heraklion, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6005-4006","authenticated-orcid":false,"given":"Antonios","family":"Douros","sequence":"additional","affiliation":[{"name":"Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada"},{"name":"Departments of Medicine and Epidemiology, McGill University, Montreal, QC, Canada"},{"name":"Institute of Clinical Pharmacology and Toxicology, Charit\u00e9 - Universit\u00e4tsmedizin Berlin, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,5,26]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504720"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611925"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1812389"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2004967"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1515920"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1811744"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022190"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911303"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024816"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S009"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2019.11.036"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2019.1602116"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k4365"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2020.10.046"},{"key":"cit0015","doi-asserted-by":"crossref","first-page":"m2812","DOI":"10.1136\/bmj.m2812","volume":"370","author":"Fralick M","year":"2020","journal-title":"BMJ"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.7326\/M20-0289"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-013-0128-8"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.9734\/BJMMR\/2017\/33253"},{"key":"cit0019","volume":"2020","author":"Gao F","year":"2020","journal-title":"Endocrinology, Diabetes Metab Case Rep"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.7326\/L20-0549"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2016.08.025"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12549"},{"key":"cit0023","unstructured":"FDA - Canagliflozin. 2017. (Accessed 05.02.2021, at 2021 02 05 https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/204042s026lbl.pdf.)"},{"key":"cit0024","unstructured":"FDA - Dapagliflozin. 2018. (Accessed 05.02.2021, at 2021 02 05 https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/202293s015lbl.pdf.)"},{"key":"cit0025","unstructured":"FDA - Ertugliflozin. 2017. (Accessed 05.02.2021, at 2021 02 05 https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/209803s000lbl.pdf.)"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01148-3"},{"issue":"6","key":"cit0028","first-page":"364","volume":"40","author":"Ndefo UA","year":"2015","journal-title":"P T"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0937-z"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-020-00875-1"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2018.1551877"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13186"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.109.029165"},{"key":"cit0034","unstructured":"FDA - Empagliflozin Pharmacology Reviews. 2013. (Accessed 14.02.2021, at 2021 02 14 https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2014\/204629Orig1s000PharmR.pdf.)"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.17265\/2159-5313\/2016.09.003"},{"key":"cit0036","unstructured":"FDA - Canaglifozin Pharmacology Reviews. 2014. (Accessed 21.02.2021, at 2021 02 21 https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2014\/204353Orig1s000PharmR.pdf.)"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(03)80316-8"},{"key":"cit0038","volume-title":"Atorvastatin. StatPearls. Treasure Island (FL): Statpearls publishing copyright \u00a9 2020","author":"McIver LA","year":"2020"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2009.00453.x"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-8206.2004.00299.x"},{"key":"cit0041","unstructured":"FDA - Simvastatin. 2008. (Accessed 05.02.2021, at 2021 02 05 https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2008\/019766s076lbl.pdf.)"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcte.2017.01.004"},{"key":"cit0043","unstructured":"FDA - Pivastatin. 2019. (Accessed 05.02.2021, at 2021 02 05 https:\/\/s3-us-west-2.amazonaws.com\/drugbank\/cite_this\/attachments\/files\/000\/004\/667\/original\/FDA_Label_-_Pitavastatin.pdf?1564609735.)"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-007-9519-6"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200342130-00005"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2012.163"},{"key":"cit0047","first-page":"3418204","volume":"2017","author":"Salna MP","year":"2017","journal-title":"Case Rep Derm Sci"},{"key":"cit0048","unstructured":"FDA - Rosuvastatin. 2019. (Accessed 05.02.2021, at 2021 02 05 https:\/\/s3-us-west-2.amazonaws.com\/drugbank\/cite_this\/attachments\/files\/000\/004\/649\/original\/FDA_Label_-_Rosuvastatin.pdf?1563989473.)"},{"key":"cit0049","unstructured":"FDA - Atorvastatin. 2018. (Accessed 05.02.2021, at 2021 02 05 https:\/\/s3-us-west-2.amazonaws.com\/drugbank\/cite_this\/attachments\/files\/000\/004\/670\/original\/FDA_Label_-_atorvastatin.pdf?1565199067.)"},{"key":"cit0050","volume-title":"Foye\u2019s principles of medicinal chemistry: Philadelphia: Lippincott","author":"Foye WO","year":"2008"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.104.002477"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.108.021410"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1211\/jpp.57.10.0009"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.105.085589"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703920"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.79"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-014-1563-4"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.02.034"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.109.203596"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1097\/01.fpc.0000170913.73780.5f"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.113.056309"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2006.09.010"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.106.012930"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1021\/mp200103h"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.068056"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2006.03.003"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-011-0098-x"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.166"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.5414\/CP202117"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.472"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2020.100765"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afy169"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13421"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2015.1034105"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.01.085"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.03.009"},{"key":"cit0077","unstructured":"Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report (Altmetric). 2020. (Accessed 22.02.2021, at 2021 02 22 https:\/\/annals.altmetric.com\/details\/87107244.)"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.277"},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.1097\/01.ccm.0000528447.29915.42"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8227(94)90062-0"}],"container-title":["Expert Opinion on Drug Metabolism &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425255.2021.1921735","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T16:35:45Z","timestamp":1698942945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425255.2021.1921735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,26]]},"references-count":80,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6,3]]}},"alternative-id":["10.1080\/17425255.2021.1921735"],"URL":"https:\/\/doi.org\/10.1080\/17425255.2021.1921735","relation":{},"ISSN":["1742-5255","1744-7607"],"issn-type":[{"value":"1742-5255","type":"print"},{"value":"1744-7607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,26]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-03-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}